Allogene Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PFIZER INC | 11/13/2025 | 22.03 M | $27.32 M | 0.00% | 10.06% |
| TPG GP A, LLC | 11/14/2025 | 18.72 M | $23.21 M | 0.00% | 8.55% |
| BLACKROCK, INC. | 11/12/2025 | 17.51 M | $21.72 M | -2.14% | 8.00% |
| CITADEL ADVISORS LLC | 11/14/2025 | 13.97 M | $17.32 M | 36.27% | 6.38% |
| VANGUARD GROUP INC | 11/07/2025 | 9.02 M | $11.19 M | 9.22% | 4.12% |
| PRIMECAP MANAGEMENT CO/CA/ | 11/12/2025 | 7.08 M | $8.78 M | 23.78% | 3.23% |
| WOODLINE PARTNERS LP | 11/14/2025 | 4.36 M | $5.41 M | 0.00% | 1.99% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/14/2025 | 3.87 M | $4.80 M | 0.00% | 1.77% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 3.83 M | $4.75 M | 1.03% | 1.75% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 3.68 M | $4.56 M | -8.77% | 1.68% |
| UBS GROUP AG | 11/13/2025 | 3.57 M | $4.43 M | 75.15% | 1.63% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 3.39 M | $4.20 M | 125.59% | 1.55% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 3.38 M | $4.20 M | 109.74% | 1.55% |
| PATIENT SQUARE CAPITAL LP | 11/10/2025 | 2.98 M | $3.70 M | 13.15% | 1.36% |
| WILDCAT CAPITAL MANAGEMENT, LLC | 11/14/2025 | 2.92 M | $3.62 M | 0.00% | 1.33% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 2.89 M | $3.59 M | 73.28% | 1.32% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 2.78 M | $3.45 M | 57.38% | 1.27% |
| STATE STREET CORP | 11/14/2025 | 2.76 M | $3.42 M | 1.20% | 1.26% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 2.09 M | $2.59 M | -23.60% | 0.96% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.85 M | $2.30 M | 2,199.01% | 0.85% |
| VIDA VENTURES ADVISORS, LLC | 11/03/2025 | 1.80 M | $2.23 M | 0.00% | 0.82% |
| ABRDN PLC | 11/07/2025 | 1.58 M | $1.96 M | 82.45% | 0.72% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.38 M | $1.71 M | 0.00% | 0.63% |
| MORGAN STANLEY | 11/14/2025 | 1.30 M | $1.61 M | 113.34% | 0.59% |
| NORTHERN TRUST CORP | 11/14/2025 | 1.28 M | $1.59 M | 0.42% | 0.58% |
| JANE STREET GROUP, LLC | 11/14/2025 | 1.22 M | $1.51 M | 194.64% | 0.56% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.20 M | $1.49 M | -78.13% | 0.55% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 1.17 M | $1.44 M | -5.46% | 0.53% |
| ROYAL BANK OF CANADA | 11/14/2025 | 1.10 M | $1.36 M | 11.38% | 0.50% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 974.32 K | $1.21 M | -1.33% | 0.45% |
| JPMORGAN CHASE & CO | 11/26/2025 | 908.73 K | $1.13 M | -2.71% | 0.42% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 894.31 K | $1.11 M | 1.74% | 0.41% |
| XTX TOPCO LTD | 11/14/2025 | 774.20 K | $960.01 K | 2,687.71% | 0.35% |
| FMR LLC | 11/13/2025 | 710.96 K | $881.59 K | -27.67% | 0.32% |
| BARCLAYS PLC | 11/12/2025 | 599.00 K | $742.76 K | -7.18% | 0.27% |
| CITIGROUP INC | 11/10/2025 | 594.10 K | $736.68 K | -7.54% | 0.27% |
| LYNX1 CAPITAL MANAGEMENT LP | 11/13/2025 | 546.12 K | $677.19 K | -95.06% | 0.25% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 533.81 K | $659.00 K | 657.54% | 0.24% |
| ZACKS INVESTMENT MANAGEMENT | 11/14/2025 | 526.13 K | $652.40 K | 2.70% | 0.24% |
| INVESCO LTD. | 11/13/2025 | 525.31 K | $651.39 K | 32.48% | 0.24% |
| MOLONEY SECURITIES ASSET MANAGEMENT, LLC | 11/05/2025 | 514.00 K | $637.36 K | 92.15% | 0.23% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/14/2025 | 489.98 K | $607.57 K | -0.91% | 0.22% |
| CERITY PARTNERS LLC | 10/22/2025 | 466.73 K | $578.75 K | 16.61% | 0.21% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 463.90 K | $575.23 K | 100.00% | 0.21% |
| RAIFFEISEN BANK INTERNATIONAL AG | 11/10/2025 | 450.00 K | $571.50 K | 11.94% | 0.21% |
| TD ASSET MANAGEMENT INC | 11/10/2025 | 414.07 K | $513.45 K | -24.08% | 0.19% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 401.87 K | $498.32 K | 7.16% | 0.18% |
| AUSTRALIANSUPER PTY LTD | 11/03/2025 | 382.14 K | $473.86 K | 100.00% | 0.17% |
| IEQ CAPITAL, LLC | 11/14/2025 | 376.06 K | $466.31 K | 101.99% | 0.17% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 296.50 K | $367.66 K | 0.00% | 0.14% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Allogene Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 222 institutional investors and hedge funds held shares of Allogene Therapeutics, Inc.. The most heavily invested institutionals were:
PFIZER INC: 22.03 M
TPG GP A, LLC: 18.72 M
BlackRock, Inc.: 17.51 M
CITADEL ADVISORS LLC: 13.97 M
VANGUARD GROUP INC: 9.02 M
PRIMECAP MANAGEMENT CO/CA/: 7.08 M
74.22% of Allogene Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 201.41 M shares in the last 24 months. This purchase volume represents approximately $290.02 M in transactions.